Nath Bio-Genes (India) Ltd Share Price Today - Nath Bio-Genes (India) Ltd Stock Price Live NSE/BSE

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN BSE: 537291

₹171.21

(-1.81%)

Wed, 20 May 2026, 03:52 am

MTF 5xInvest in Nath Bio-Genes (India) Ltd with 5x Leverage Buy with MTF

Market Cap3.25B

PE Ratio8.11

Dividend1.17

Process Industries

Agricultural Commodities/Milling

24.5K

Nath Bio-Genes (India) Share Price Live Chart

1 Day

(-1.81%)

No Result Found

Summary

Market Cap
304.44
Net Profit
38.60
P/B
0.43
Sector P/E
47.96
P/E
7.18
EV/EBITDA
5.65
Debt/Equity (Industry)
0.20
Interest Cover (Industry)
18.26
ROCE (Industry)
16.60
RONW (Industry)
15.14
ROE
6.15
ROCE
6.86
Debt/Equity
0.19
EPS (TTM)
19.06
Dividend Yield
1.25
Book Value
358.06
Interest Cover
4.81

Analysis

all

Pros

Nath Bio-Genes (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Nath Bio-Genes (India) is profitable, therefore cash runway is not a concern.
Nath Bio-Genes (India) is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 6.8x debt.
Nath Bio-Genes (India)'s cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Nath Bio-Genes (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Nath Bio-Genes (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not well covered by operating cash flow (13.6%, less than 20% of total debt).
High level of physical assets or inventory.
Nath Bio-Genes (India) is not covered by any analysts.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	45.60	45.60	45.60	45.60	45.60
FII	0.23	0.31	0.32	0.41	0.21
DII	0.01	0.01	0.76	2.25	3.94
Public	54.16	54.08	53.32	51.75	50.25
Government	0	0	0	0	0

Technical Analysis

RSI

45.30

MACD

0.41

50 DMA

156.30

200 DMA

160.29

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	319.34	248.54	222.27	177.74	151.47	106.94	36.14
Fibonacci	248.54	221.49	204.78	177.74	150.69	133.98	106.94
Camarilla	215.48	208.99	202.50	177.74	189.52	183.03	176.54

Pivots Level: Classic

+141.60

319.34

+70.80

248.54

+44.54

222.27

177.74

Pivot Point

LTP: 160.27

-26.26

151.47

-70.80

106.94

-141.60

36.14

Moving Average

SMAEMA

Period

Value

10-EMA
164.79
20-EMA
166.08
30-EMA
164.37
50-EMA
160.83
100-EMA
158.21
200-EMA
161.73

Announcement Date	Purpose	Action	Ex Date
04 May 2026	board-meetings	Quarterly Results, Final Dividend
31 Jan 2026	board-meetings	Quarterly Results
13 Nov 2025	board-meetings	Quarterly Results
14 Jul 2025	dividend	Final Dividend - Rs. - 2	14 Aug 2025
29 Apr 2025	agm
29 Apr 2025	dividend	₹2.00 Dividend /Share	14 Aug 2025
12 Jul 2024	agm	Annual General Meeting	13 Aug 2024
09 Jul 2024	dividend	Final Dividend - Rs. - 2	09 Aug 2024
08 May 2024	agm
08 May 2024	dividend	₹2.00 Dividend /Share	09 Aug 2024

Nath Bio-Genes (India) Ltd

Britannia Industries Ltd

Marico Ltd

Hindustan Unilever Ltd

Varun Beverages Ltd

Nestle India Ltd

Nath Bio-Genes (India) Ltd About

Nath Bio-Genes (India) is engaged in the business of Production, Processing, and Marketing of Hybrid and GM Seeds. The Company has a product range of Field crops, Vegetable crops and Plant Nutrient Supplements.

Industry

Miscellaneous

Founded

1993

Headquarters

CEO

Satish Kagliwal

Employees

Contact

Website

http://www.nathbiogenes.com

investor@nathbiogenes.com; info@nathseeds.com

Phone

91-240-2376314

Location

Nath House Nath Road, P B No 318, AURANGABAD, Maharashtra, 431005

Year	History
2000	The company was converted into a Public Limited Company under the name SHIVNATH FARMS LTD.
2001	The company changed its name to Nath Bio-Genes (India) Ltd. The entire business and assets of Seeds Division of Nath Seeds Limited were transferred to Nath Bio-Genes (India) Limited.
2003	The Scheme of Arrangement was approved by the Hon'ble High Court of Bombay.
2014	The company appointed Mrs. Sweta Garodia as a Director.
2020	The company acquired technology from Global Transgenes Limited, an associate company.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
ADITYA BIRLA SUN LIFE MUTUAL FUND	bulk	Sell	126830	165.08	19 Sept 2025
BAKULESH SHAH PRIVATE TRUST	bulk	Sell	168000	152.5	05 Mar 2025
BAKULESH TRAMBAKLAL SHAH	bulk	Buy	168000	152.5	05 Mar 2025
ADROIT FINANCIAL SERVICES PVT LTD	bulk	Buy	133322	261.12	04 Jul 2024
ADROIT FINANCIAL SERVICES PVT LTD	bulk	Sell	133322	262.2	04 Jul 2024
JAINAM BROKING LIMITED	bulk	Buy	111376	245.86	01 Jul 2024
JAINAM BROKING LIMITED	bulk	Sell	6775	247.38	01 Jul 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	103767	236.15	01 Jul 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	103767	236.35	01 Jul 2024
AKASH FARMS LLP	block	Buy	504000	217	21 Feb 2024

Nath Bio-Genes (India) Ltd News

Nath Bio-Genes Q4 FY26 Audio Recording Submitted to Exchanges

Nath Bio-Genes submits audio recording of Q4 FY26 conference call to BSE and NSE per SEBI Regulation 30. Recording available on company website; CFO Amol Gupta signed off on May 11, 2026.

12 May 2026

companies

Nath Bio-Genes Q4 FY26 Earnings Call: Key Highlights

Nath Bio-Genes Q4 FY26 earnings call transcript submitted. FY26 revenue grew 19% YoY to INR 4,316 mn; maize volumes surged 54% YoY; Uzbekistan JV contributed INR 15 crores to top line for first time.

11 May 2026

companies

Nath Bio-Genes Submits Q4FY26 Conference Call Audio Recording

Nath Bio-Genes (India) Limited submits audio recording of its Q4FY26 conference call held on May 5, 2026, per SEBI Regulation 30, accessible on the company website.

11 May 2026

companies

Nath Bio-Genes Posts Audited FY26 Results; Dividend Declared

Nath Bio-Genes reports audited standalone revenue of Rs. 43,159.72 Lakhs for FY26, with net profit of Rs. 4,442.57 Lakhs. Board recommends dividend of Rs. 2/- per share for FY26.

05 May 2026

companies

Nath Bio-Genes Posts FY26 Revenue of INR 4,316 Mn

Nath Bio-Genes reports FY26 total revenue of INR 4,316 Mn, up from INR 3,623 Mn in FY25, with net worth rising to INR 6,893 Mn and EPS at 23.42.

05 May 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800